Translating Diabetes

Over recent decades, the incidence of metabolic diseases such as obesity and diabetes has risen to epidemic proportions. Projections into the future suggest increasingly unmet patient needs and an unsustainable challenge for health care systems. Simultaneously, the drug discovery process is facing its own challenges. The number of pharmaceutical companies who are able to conduct expensive late stage clinical trials is declining. Funding for academic laboratories and biotechnology operations is limited. Novel strategies and new insights are needed to treat these diseases.

The 2014 EMBO | EMBL Symposium will focus on "translation" from bench to bedside and from model organism to the clinic.
+ show speakers and program
Speakers

Keynote Speakers


Domenico Accili
Columbia University, USA


Stephen O'Rahilly
University of Cambridge Metabolic Research Laboratories - Institute of Metabolic Science, UK


Celeste Simon
University of Pennsylvania, USA


Confirmed Speakers


Carolyn Cummins
University of Toronto, Canada

collombat
Patrick Collombat
Institut de Biologie de Valrose, France


Hans-Ulrich Häring
University of Tübingen, Germany


Peter Havel
University of California, Davis, USA

kaestner
Klaus Kaestner
University of Pennsylvania School of Medicine, USA


Anastasia Kralli
The Scripps Research Institute, USA


Heiko Lickert
Helmholtz Zentrum München, Institute of Stem Cell Research, Germany


Hernan Lopez-Schier
Helmholtz Zentrum München, Germany


Kathrin Maedler
University of Bremen, Germany


Adriana Maggi
The University of Milan, Italy


John Reynolds
Trinity College Dublin, Ireland


Michael Ristow
ETH Zürich, Switzerland


Varda Rotter
Weizmann Institute of Science, Israel


Jon Shah
Forschungszentrum Jülich, Germany


Dana Small
The John B. Pierce Laboratory, USA

smith
Steven Smith
Translational Research Institute for Metabolism and Diabetes, Sanford-Burnham Medical Research Institute, USA


Scott Sternson
Janelia Farm, USA

stoffel
Markus Stoffel
ETH Zurich, Switzerland


Lori Sussel
Columbia University, USA


Kirsi A. Virtanen
Turku PET Centre, University of Turku and Turku University Hospital, Finland


Matthias von Herrath
La Jolla Institute for Allergy & Immunology, USA


Christopher Wright
Vanderbilt University, USA


Thomas Wunderlich
University of Cologne, CECAD - Cluster of Excellence, Germany


Lori Zeltser
The Naomi Berrie, Columbia University, USA


Anette-Gabriele Ziegler
Helmholtz Zentrum München, Germany

30 Apr - 3 May 2014
heidelberg
Germany
meeting website